Flagship Pioneering as of Dec. 31, 2019
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 9 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 55.6 | $995M | 51M | 19.56 | |
| Rubius Therapeutics | 20.3 | $364M | 38M | 9.50 | |
| Denali Therapeutics (DNLI) | 7.8 | $139M | 8.0M | 17.42 | |
| Kaleido Biosciences Ord (KLDO) | 4.9 | $87M | 17M | 5.02 | |
| Seres Therapeutics (MCRB) | 4.2 | $74M | 22M | 3.45 | |
| Evelo Biosciences | 4.1 | $74M | 18M | 4.06 | |
| Axcella Health Inc equity | 2.0 | $35M | 8.7M | 4.01 | |
| Syros Pharmaceuticals | 1.1 | $20M | 2.9M | 6.91 | |
| Transmedics Group (TMDX) | 0.0 | $0 | 0 | 0.00 |
